Literature DB >> 20949364

Health effects of dietary Maillard reaction products: the results of ICARE and other studies.

Frédéric J Tessier1, Inès Birlouez-Aragon.   

Abstract

In food science the Maillard reaction is well known to cause degradation of amino acids and an overall decrease in the nutritional value of foods that have been subjected to heat in processing. There has been evidence more recently of the endogenous formation of some Maillard reaction products (MRPs) in biological systems and their association with pathophysiological conditions including diabetes, renal disease and cardiovascular disease. Several studies have suggested that dietary MRPs increase the in vivo pool of MRPs after intestinal absorption and contribute to the development of diabetes and related complications. This review focuses on the animal and human studies which have assessed the eventual implications of dietary MRPs on human health, highlighting the different diets tested, the experimental designs and the biomarkers selected to estimate the health effects. The results of these studies are compared to those of the recently published ICARE study. In this latter study an accurate determination of the MRP content of the diets was achieved, allowing the calculation of the contribution of individual food groups to daily MRP intakes in a regular western diet.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20949364     DOI: 10.1007/s00726-010-0776-z

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  24 in total

1.  Association between habitual dietary and lifestyle behaviours and skin autofluorescence (SAF), a marker of tissue accumulation of advanced glycation endproducts (AGEs), in healthy adults.

Authors:  Nicole J Kellow; Melinda T Coughlan; Christopher M Reid
Journal:  Eur J Nutr       Date:  2017-06-27       Impact factor: 5.614

2.  Contribution of dietary advanced glycation end products (AGE) to circulating AGE: role of dietary fat.

Authors:  Kathleen E Davis; Chandan Prasad; Parakat Vijayagopal; Shanil Juma; Beverley Adams-Huet; Victorine Imrhan
Journal:  Br J Nutr       Date:  2015-09-22       Impact factor: 3.718

3.  Prognostic potential and tumor growth-inhibiting effect of plasma advanced glycation end products in non-small cell lung carcinoma.

Authors:  Babett Bartling; Hans-Stefan Hofmann; Antonia Sohst; Yvonne Hatzky; Veronika Somoza; Rolf-Edgar Silber; Andreas Simm
Journal:  Mol Med       Date:  2011-05-24       Impact factor: 6.354

Review 4.  Avenues for post-translational protein modification prevention and therapy.

Authors:  Mengyao Tang; Sahir Kalim
Journal:  Mol Aspects Med       Date:  2022-02-25

5.  Extending the spectrum of α-dicarbonyl compounds in vivo.

Authors:  Christian Henning; Kristin Liehr; Matthias Girndt; Christof Ulrich; Marcus A Glomb
Journal:  J Biol Chem       Date:  2014-08-27       Impact factor: 5.157

6.  Long-term intake of animal flesh and risk of developing hypertension in three prospective cohort studies.

Authors:  Lea Borgi; Gary C Curhan; Walter C Willett; Frank B Hu; Ambika Satija; John P Forman
Journal:  J Hypertens       Date:  2015-11       Impact factor: 4.844

7.  Molecular annotation of food - towards personalized diet and precision health.

Authors:  Junai Gan; Justin B Siegel; J Bruce German
Journal:  Trends Food Sci Technol       Date:  2019-07-24       Impact factor: 12.563

Review 8.  Advanced glycation end products (AGEs) and its receptor, RAGE, modulate age-dependent COVID-19 morbidity and mortality. A review and hypothesis.

Authors:  Durai Sellegounder; Parisa Zafari; Misagh Rajabinejad; Mahdi Taghadosi; Pankaj Kapahi
Journal:  Int Immunopharmacol       Date:  2021-05-24       Impact factor: 5.714

9.  Molecular characterization of sequence-driven peptide glycation.

Authors:  Michelle T Berger; Daniel Hemmler; Alesia Walker; Michael Rychlik; James W Marshall; Philippe Schmitt-Kopplin
Journal:  Sci Rep       Date:  2021-06-24       Impact factor: 4.379

10.  Biodistribution and elimination study of fluorine-18 labeled Nε-carboxymethyl-lysine following intragastric and intravenous administration.

Authors:  Hongzeng Xu; Zhongqun Wang; Yan Wang; Shengda Hu; Naifeng Liu
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.